Collagen implant versus gluteus maximus flap for perineal closure after extended abdominoperineal excision: NEAPE randomized clinical trial
BJS Open · 2026
DOI: 10.1093/bjsopen/zrag079 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJS Open, 2026. Verfasst von Martin Rutegård und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Collagen, Rectal Neoplasms, Perineum, Proctectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: County Council of Västerbotten, Sweden, Swedish Society of Medicine, Swedish Society for Colon and Rectal Surgeons.
Abstract (Originalsprache)
Background
Optimal reconstruction of the perineal defect after extended abdominoperineal excision remains uncertain, and randomized comparisons between biological mesh and myocutaneous flaps are lacking. This trial assessed whether an acellular porcine collagen implant (APCI) is non-inferior to a gluteus maximus myocutaneous flap (GMF) for pelvic floor reconstruction.
Methods
NEAPE was a multicentre, randomized, non-inferiority trial conducted in eight Nordic referral centres. Adults undergoing extended abdominoperineal excision for rectal cancer were randomized to reconstruction with an APCI or unilateral GMF. The primary outcome was the proportion of patients underperforming in the timed-stands test at 6 months, defined relative to age- and sex-matched reference values. The non-inferiority margin was −10%.
Results
Eighty-three patients were included in the modified intention-to-treat population (mean(standard deviation) age 68(10) years; 31% female). At 6 months, 71% of patients (25 of 35) in the implant group and 60% of patients (20 of 33) in the flap group underperformed. The risk difference was −11% (one-sided 95% confidence interval −30% to ∞), and non-inferiority was not demonstrated.
Conclusion
The APCI did not demonstrate non-inferiority compared with the GMF. The direction of the effect favoured the flap, with results compatible with worse functional outcomes in the implant group. Registration number ClinicalTrials.gov NCT01347697.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University, Umeå, Sweden.
- Oulu University Hospital, Medical Research Centre Oulu, Oulu, Finland.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Surgery, Skåne University Hospital, Malmö, Lund University, Lund, Sweden.
ORCID-Profile: Martin Rutegård
Förderung
- County Council of Västerbotten, Sweden
- Swedish Society of Medicine
- Swedish Society for Colon and Rectal Surgeons
Zitieren
APA
Rutegård, M., Svensson, J., Rutegård, J., Rautio, T., Nilsson, P. J., Sjöström, O., Lydrup, M. L., Odensten, C., Söderström, A., Dahlberg, M., & Haapamäki, M. M. (2026). Collagen implant versus gluteus maximus flap for perineal closure after extended abdominoperineal excision: NEAPE randomized clinical trial. BJS Open. https://doi.org/10.1093/bjsopen/zrag079
Vancouver
Rutegård M, Svensson J, Rutegård J, Rautio T, Nilsson PJ, Sjöström O, et al. Collagen implant versus gluteus maximus flap for perineal closure after extended abdominoperineal excision: NEAPE randomized clinical trial. BJS Open. 2026. doi:10.1093/bjsopen/zrag079
BibTeX
@article{Rutegrd2026,
author = {Rutegård, Martin and Svensson, Johan and Rutegård, Jörgen and Rautio, Tero and Nilsson, Per J and Sjöström, Olle and Lydrup, Marie-Louise and Odensten, Christoffer and Söderström, Andreas and Dahlberg, Michael and Haapamäki, Markku M},
title = {Collagen implant versus gluteus maximus flap for perineal closure after extended abdominoperineal excision: NEAPE randomized clinical trial},
journal = {BJS Open},
year = {2026},
doi = {10.1093/bjsopen/zrag079}
}
EUVIMED